Changing Public Perception of the Pharmaceutical Industry

September 13, 2010

Applied Clinical Trials

2004, Merck voluntarily withdraws its COX-2 selective nonsteroidal anti-inflammatory drug for the treatment of pain. This event affected the industry’s image and increased political, public, and industry focus on product safety and risk management.

Related Content: